首页|期刊导航|山东医药|锌剂预处理对丙咪嗪抗抑郁药效的增强作用及其机制

锌剂预处理对丙咪嗪抗抑郁药效的增强作用及其机制OACSTPCD

Enhancing effect of zinc pretreatment on antidepressant effect of imipramine and its mechanism

中文摘要英文摘要

目的 观察锌剂预处理对丙咪嗪抗抑郁药效的增强作用,并探讨相关机制.方法 将SD大鼠随机分为模型组、锌组、丙咪嗪组、锌+丙咪嗪组、锌+H89+丙咪嗪组及对照组.模型组、锌组、丙咪嗪组、锌+丙咪嗪组、锌+H89+丙咪嗪组采用电击箱构建习得性无助抑郁模型;对照组大鼠同样放于电箱中,但不给予电击.造模结束后,模型组腹腔注射生理盐水;锌组腹腔注射葡萄糖酸锌连续3 d;丙咪嗪组腹腔注射丙咪嗪、单次给药;锌+丙咪嗪组腹腔注射葡萄糖酸锌连续3 d,第4天给予丙咪嗪;锌+H89+丙咪嗪组腹腔注射葡萄糖酸锌连续3 d,在第1天锌剂给药后注射H89[蛋白激酶A(PKA)抑制剂]注射液,在第4天给予丙咪嗪;对照组腹腔注射生理盐水.大鼠给药结束24 h后进行电击穿梭逃避试验及强迫游泳行为学测试评价抑郁样行为,采集外侧缰核(LHb)检测细胞色素氧化酶及星形胶质细胞中的内向整流钾通道4.1(Kir4.1)蛋白.结果 锌组、丙咪嗪组、锌+H89+丙咪嗪组和模型组强迫游泳不动时间和逃避失败次数高于对照组;锌+丙咪嗪组强迫游泳不动时间和逃避失败次数低于模型组、锌组、丙咪嗪组及锌+H89+丙咪嗪组(P均<0.01).锌组、丙咪嗪组、锌+H89+丙咪嗪组和模型组LHb中细胞色素氧化酶表达及Kir4.1阳性星形胶质细胞数高于对照组,锌组、丙咪嗪组、锌+丙咪嗪组细胞色素氧化酶表达及Kir4.1阳性星形胶质细胞数低于模型组,锌+丙咪嗪组细胞色素氧化酶表达及Kir4.1阳性星形胶质细胞数低于锌组、丙咪嗪组(P均<0.01).结论 锌剂预处理可增强丙咪嗪的抗抑郁药效,其作用机制可能与调控Kir4.1表达、抑制LHb簇状放电有关,这一作用可被PKA抑制剂H89所阻断.

Objective To investigate the enhancing effect of zinc pretreatment on antidepressant effect of imipra-mine and to explore the underlying mechanism.Methods SD rats were randomly divided into the model group,zinc group,imipramine group,zinc+imipramine group,zinc+H89+imipramine group,and control group.In the model group,zinc group,imipramine group,zinc+imipramine group,zinc+H89+imipramine group,we constructed the learned helplessness depression models by using the electric box;the rats in the control group were also placed in the elec-tric box,but no electric shock was given.After modeling,rats in the model group were intraperitoneally injected with nor-mal saline;rats in the zinc group were intraperitoneally injected with zinc gluconate for 3 consecutive days;rats in the imipramine group were intraperitoneally injected with imipramine as a single dose;rats in the zinc+imipramine group were intraperitoneally injected with zinc gluconate for 3 consecutive days and were given imipramine on the 4th day;rats in the zinc+H89+imipramine group were intraperitoneally injected with zinc gluconate for 3 consecutive days,and were in-jected with H89[protein kinase A(PKA)inhibitor]injection after zinc administration on the first day and were given imip-ramine on the 4th day;rats in the normal control group were injected with normal saline.Depressive behaviors were as-sessed 24 h after the last administration using the shock shuttle-escape test and forced swimming test.Subsequently,the lateral habenular(LHb)was collected to evaluate the expression of cytochrome oxidase and Kir4.1 protein in astrocytes.Results In the forced swimming test,the zinc group,imipramine group,zinc+H89+imipramine group,and LH model group exhibited significantly longer immobility time compared with the control group.Similarly,in the shock shuttle-es-cape test,these groups showed more failure escape time compared with the control group.Notably,the zinc+imipramine group displayed significantly shorter immobility time and fewer failures in both tests compared with the model group,zinc group,imipramine group and zinc+H89+imipramine group(all P<0.01).The expression levels of cytochrome oxidase and Kir4.1 in the zinc group,imipramine group,zinc+H89+imipramine group,and model group were higher than those of the control group,the expression levels of cytochrome oxidase and Kir4.1 in the zinc group,imipramine group,zinc+imipramine group were lower than those of the model group,and the zinc+imipramine group exhibited significantly lower expression levels of cytochrome oxidase and Kir4.1 in comparison with those of the zinc group and imipramine group(all P<0.01).Conclusion Zinc pretreatment can rapidly enhance the antidepressant effects of imipramine.Its mechanism of action may be related to regulating the expression of Kir4.1 and inhibiting the clustered discharge of the LHb,and this effect can be blocked by the PKA inhibitor H89.

吴少华;余敏玲;任麟祥;危智盛

广东药科大学附属第一医院神经内科,广州 510080

临床医学

锌剂丙咪嗪抗抑郁药物外侧缰核

Zincimipramineantidepressantlateral habenular

《山东医药》 2024 (020)

25-29 / 5

广东省自然科学基金面上项目(2021A1515011695).

10.3969/j.issn.1002-266X.2024.20.006

评论